88%
Finnrick rating
#7 of 186 Tirzepatide vendors
26 of 29 classifiable tests passed
customers 4.9★ (17)
methodology · Purity focus
Finnrick analysis · Tirzepatide

PeptiSlim Tirzepatide shows a recovery pattern under the purity-focus method, but its history includes a failed-identity 0 mg result, a +40% overfill, and a 99.15% purity miss. Recent results pass, with one +32% fill near the limit.

methodology →
vendor intelligence report
Vendor Intelligence Report: PeptiSlim

Vendor-published COAs, Hong Kong contacts, and a Limeiren TikTok trail point past the US storefront to a Limeiren manufacturer layer. The report also maps AU placeholder addresses, hidden payment-descriptor language, brand-lineage leads, and regulatory exposure.

27 pages5 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatideselected
$0.64
88%
29
2
GHK-Cu
-
87%
6
3
Retatrutide
$1.00
87%
26
4
Semaglutide
$0.64
71%
4
5
Cagrilintide
$1.53
57%
2
6
Tesamorelin
$2.30
42%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%4 Mar 2026: 79%16 Mar 2026: 80%25 Mar 2026: 81%17 Jun 2026: 82%17 Jun 2026: 83%17 Jun 2026: 83%22 Jun 2026: 84%23 Jun 2026: 85%26 Jun 2026: 85%26 Jun 2026: 86%26 Jun 2026: 86%26 Jun 2026: 87%26 Jun 2026: 87%21 Jul 2026: 88%21 Jul 2026: 88%9 Aug 2026: current 88%79%82%88%Mar 26Aug 26
Showing Tirzepatide tests only
PeptiSlim Tirzepatide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
21 Jul 2026Pass
Tested
lab nameView COA
21 Jul 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
26 Jun 2026Pass
Tested
lab nameView COA
23 Jun 2026Pass
Tested
lab nameView COA
22 Jun 2026Pass
Tested
lab nameView COA
17 Jun 2026Pass
Tested
lab nameView COA
1-10 of 29

About PeptiSlim test results from Finnrick

PeptiSlim is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 71 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible PeptiSlim peptides in this dataset are Tirzepatide (29 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 71 recent tests.

Corrections
No corrections.